P.O. Box 50030 London, ON N6A 6H8 info@rett.ca (519) 474-6877

Taysha Community Updates – September 2021

Taysha Gene Therapies has shared the following updates from an educational event held this month with investors. Progress is continuing on TSHA-102, the investigational gene therapy for Rett syndrome. They plan to enroll patients 18 years or older for the first clinical trial.

September 22, 2021 Update

September 24, 2021 Update